Skip to content
Subscriber Only
Business
Prognosis

Rapid New Covid-19 Test From Access Bio Cleared in U.S.

  • Screening produces results in 10 minutes, costs under $20
  • Access to speedy tests shown to be crucial, remains limited
Video player cover image
Trump: Millions of Virus Rapid Tests Will Be Distributed

A new 10-minute Covid-19 test that doesn’t need added equipment to process has been cleared by the U.S. Food and Drug Administration, manufacturer Access Bio, Inc. said on Tuesday.

The assay, known as CareStart, is among a group of new antigen tests that detect the novel coronavirus by looking for proteins on its surface.